247 related articles for article (PubMed ID: 32651586)
1. The Importance of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
Schlom J; Donahue RN
J Infect Dis; 2020 Oct; 222(9):1435-1438. PubMed ID: 32651586
[TBL] [Abstract][Full Text] [Related]
2. Developing Covid-19 Vaccines at Pandemic Speed.
Lurie N; Saville M; Hatchett R; Halton J
N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
[No Abstract] [Full Text] [Related]
3. Progress and Concept for COVID-19 Vaccine Development.
Wu SC
Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
[No Abstract] [Full Text] [Related]
4. The race for coronavirus vaccines: a graphical guide.
Callaway E
Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
[No Abstract] [Full Text] [Related]
5. Coronavirus vaccines get a biotech boost.
Dance A
Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
[No Abstract] [Full Text] [Related]
6. Vaccines targeting SARS-CoV-2 tested in humans.
Edwards KM
Nat Med; 2020 Sep; 26(9):1336-1338. PubMed ID: 32839620
[No Abstract] [Full Text] [Related]
7. T cells found in coronavirus patients 'bode well' for long-term immunity.
Leslie M
Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
[No Abstract] [Full Text] [Related]
8. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
[No Abstract] [Full Text] [Related]
9. Is Herd Immunity Against SARS-CoV-2 a Silver Lining?
Vignesh R; Shankar EM; Velu V; Thyagarajan SP
Front Immunol; 2020; 11():586781. PubMed ID: 33101320
[No Abstract] [Full Text] [Related]
10. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
[TBL] [Abstract][Full Text] [Related]
11. The COVID-19 vaccine development landscape.
Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
[No Abstract] [Full Text] [Related]
12. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
Boudjelal M; Nehdi A; Islam I
Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
[No Abstract] [Full Text] [Related]
13. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
Heininger U
Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
[No Abstract] [Full Text] [Related]
14. Fast-and-fit vaccines.
Nat Biomed Eng; 2020 Aug; 4(8):757-758. PubMed ID: 32760006
[No Abstract] [Full Text] [Related]
15. COVID-19 shot protects monkeys.
Cohen J
Science; 2020 May; 368(6490):456-457. PubMed ID: 32355008
[No Abstract] [Full Text] [Related]
16. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
Dong H
Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
[No Abstract] [Full Text] [Related]
17. Current development of COVID-19 diagnostics, vaccines and therapeutics.
Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
[TBL] [Abstract][Full Text] [Related]
18. A vaccine is not too far for COVID-19.
Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
[No Abstract] [Full Text] [Related]
19. COVID-19 herd immunity: where are we?
Fontanet A; Cauchemez S
Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
[TBL] [Abstract][Full Text] [Related]
20. Next-generation vaccine platforms for COVID-19.
van Riel D; de Wit E
Nat Mater; 2020 Aug; 19(8):810-812. PubMed ID: 32704139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
